JAMES CROWE, MD
Medical Practice in Nashville, TN

License number
Tennessee MD27245
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
3601 Tvc, Nashville, TN 37232
Phone
(615) 322-3000

Personal information

See more information about JAMES CROWE at radaris.com
Name
Address
Phone
James Crowe, age 76
473 Henson Rd, Bristol, TN 37620
James Crowe, age 53
5902 Tyner Ln, Harrison, TN 37341
(423) 367-8389
James Crowe, age 81
535 Lakemont Dr, Rockwood, TN 37854
(865) 354-0897
James H Crowe
437 Main St, Church Hill, TN 37642
(423) 357-7561
James H Crowe
437 Grandview St, Church Hill, TN 37642
(423) 357-7561

Organization information

See more information about JAMES CROWE at bizstanding.com

James Crowe MD

3601 The Vanderbilt Clinic, Nashville, TN 37232

Industry:
Pediatrician, Internist
Phone:
(615) 322-3000 (Phone)
Description:
There are 7 doctors at this site. Surgery is not performed at this site.
James Earl Crowe Jr


James Crowe Jr

2101 20 Ave S, Nashville, TN 37212

Industry:
Consultant
Owner:
James E. Crowe Owner, inactive

Professional information

See more information about JAMES CROWE at trustoria.com
James Crowe Photo 1
Ann Scott Carell Chair At Vanderbilt University

Ann Scott Carell Chair At Vanderbilt University

Position:
Ann Scott Carell Chair at Vanderbilt University, Founder at Corbeau Biotech LLC, Professor of Pediatrics, Microbiology and Immunology at Vanderbilt University Medical Center, Director, Vanderbilt Vaccine Center at Vanderbilt University Medical Center
Location:
Greater Nashville Area
Industry:
Research
Work:
Vanderbilt University - Nashv since Jul 2013 - Ann Scott Carell Chair Corbeau Biotech LLC since Aug 2009 - Founder Vanderbilt University Medical Center since Feb 2006 - Professor of Pediatrics, Microbiology and Immunology Vanderbilt University Medical Center - Vanderbilt University, Nashville, TN, USA since 2006 - Director, Vanderbilt Vaccine Center Vanderbilt University Medical Center 2006 - 2013 - Ingram Professor of Cancer Research
Education:
University of North Carolina at Chapel Hill School of Medicine 1983 - 1987
MD, Medicine
Davidson College 1979 - 1983
BS, Premedicine
Skills:
Immunology, Vaccines, Infectious Diseases, Cell, Cell Biology, Microbiology, Biotechnology, Clinical Trials, Clinical Development, Clinical Research, Monoclonal Antibodies, Antibodies
Interests:
Viral immunology, vaccines, human antibodies
Honor & Awards:
1979-83, Stuart Scholar Davidson, 1983 PBK, ODK, AED. Davidson, 1990 Outstanding Ped Resident. Wake Med Ctr. Raleigh NC, 1990 Edward Curnen Awrd. UNC Peds, 1996 Pfizer Faculty Scholar, 1998 Basil O’Connor Scholar Res Awrd. March of Dimes, 1999 ASM Dade MicroScan Investig Awrd, 1999 Turner Scholar Awrd. Vanderbilt, 2000 Young Investig Awrd. Ped Inf Dis Soc, 2001 Young Investig Awrd. Soc for Ped Res, 2002 Judson Daland Prize. American Philosophical Soc, 2005/2008 Teacher of the Year Awrd, Vanderbilt Graduate Program, 2005 Oswald Avery Awrd. Inf Dis Soc of Amer, 2006 E. Mead Johnson Award, Soc for Ped Res, Outstanding Investig Awrd, Amer Fed for Med Res, 2007 F. Peter Guengerich Award for Mentoring Postdoctoral Fellows, Vanderbilt, 2007 Ernest W. Goodpasture Faculty Research Awrd, Vanderbilt, 2007 Chancellor's Research Awrd, Vanderbilt; 2010 Norman J. Siegel New Member Outstanding Science Award, American Pediatric Society; 2012 Mentor of the Year Award, Vanderbilt Postdoctoral Association


James Earl Crowe Photo 2
James Earl Crowe, Nashville TN

James Earl Crowe, Nashville TN

Specialties:
Pediatrics, Pediatric Infectious Diseases, Infectious Disease
Work:
Vanderbilt Pediatric Urology
3601 The Vanderbilt Clinic, Nashville, TN 37232 Vanderbilt University Medical Cnt
1161 21St Ave S, Nashville, TN 37232
Education:
University of North Carolina (1987)


James Leo Crowe Photo 3
James Leo Crowe, Houma LA

James Leo Crowe, Houma LA

Specialties:
Internal Medicine, Infectious Disease, Hospitalist
Work:
South Louisiana Medical Associates
1990 Industrial Blvd, Houma, LA 70363 Chabert Medical Ctr
1978 Industrial Blvd, Houma, LA 70363 Baptist Healthcare Group
2010 Church St, Nashville, TN 37203
Education:
Medical University of South Carolina (2004)


James Crowe Photo 4
Dr. James Crowe, Nashville TN - MD (Doctor of Medicine)

Dr. James Crowe, Nashville TN - MD (Doctor of Medicine)

Specialties:
Pediatric Infectious Disease Medicine
Address:
DEPARTMENT OF RADIOLOGY VUMC
1161 21St Ave S, Nashville 37232
(615) 343-1501 (Phone)
Vanderbilt Childrens Inf Diseas
2200 Childrens Way SUITE 9102-DOT, Nashville 37232
(615) 322-2250 (Phone)
Certifications:
Pediatric Infectious Disease Medicine, 2005, Pediatrics, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
DEPARTMENT OF RADIOLOGY VUMC
1161 21St Ave S, Nashville 37232
Vanderbilt Childrens Inf Diseas
2200 Childrens Way SUITE 9102-DOT, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Education:
Medical School
Medical University of South Carolina
Graduated: 2004
University of North Carolina At Chapel Hill
Graduated: 1987
North Carolina Memorial Hospital
Graduated: 1988
Graduated: 1990
National Institute Of Health
Graduated: 1995
Vanderbilt University Med Center
Graduated: 1996


James Crowe Photo 5
Dendritic Molecular Intracellular Transporters And Methods Of Making And Using Same

Dendritic Molecular Intracellular Transporters And Methods Of Making And Using Same

US Patent:
2008022, Sep 11, 2008
Filed:
Aug 23, 2007
Appl. No.:
11/844353
Inventors:
Eva M. Harth - Nashville TN, US
James E. Crowe - Nashville TN, US
Kui Huang - Nashville TN, US
Sharon K. Hamilton - Nashville TN, US
Heidi E. Hamm - Nashville TN, US
Bryan Voss - Nashville TN, US
International Classification:
A61K 38/05, C07C 279/02, C08G 69/02
US Classification:
514 20, 564241, 564236, 525420
Abstract:
In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to compounds comprising the structure:and at least one guanidinium residue, wherein m is zero or a positive integer. Also disclosed are methods of preparing the disclosed compounds. Also disclosed are methods of intracellular delivery comprising administering the disclosed compounds and compositions to a subject. Also disclosed are pharmaceutical compositions comprising a therapeutically effective amount of one or more compounds or compositions of the invention and a pharmaceutically acceptable carrier. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.


James Crowe Photo 6
Influenza Virus Antibodies And Immunogens And Uses Therefor

Influenza Virus Antibodies And Immunogens And Uses Therefor

US Patent:
2013028, Oct 31, 2013
Filed:
Sep 30, 2011
Appl. No.:
13/877163
Inventors:
James E. Crowe - Nashville TN, US
Jens C. Krause - Freiburg, DE
David L. Blum - Athens GA, US
Assignee:
VANDERBILT UNIVERSITY - Nashville TN
International Classification:
C07K 16/10
US Classification:
530381, 53038825, 5303873
Abstract:
The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of influenza virus infections. In particular, these antibodies may neutralize or limit the replication of influenza virus. Also disclosed are improved methods for producing such monoclonal antibodies, including novel immunogens for use in vaccination and production of protective immune responses.


James Crowe Photo 7
Human Antibodies Neutralizing Human Metapneumovirus

Human Antibodies Neutralizing Human Metapneumovirus

US Patent:
2011013, Jun 9, 2011
Filed:
Oct 4, 2007
Appl. No.:
12/311587
Inventors:
R. Anthony Williamson - La Jolla CA, US
Zhifeng Chen - Vista CA, US
Pietro Paolo Sanna - San Diego CA, US
Dennis R. Burton - La Jolla CA, US
James Crowe - Nashville TN, US
John V. Williams - Nashville TN, US
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
A61K 39/395, C07K 16/10, G01N 33/68, C12Q 1/70, A61P 31/14, A61P 37/04
US Classification:
4241371, 5303875, 5303913, 5303873, 436501, 4241591, 435 5
Abstract:
The present invention discloses methods for generating antibodies to human metapneumovirus (HMPV) polypeptides, including antibodies that immunospecifically bind to a HMPV F-protein. The invention also discloses methods for preventing, treating, or ameliorating symptoms associated with HMPV infection.


James Crowe Photo 8
Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor

Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor

US Patent:
2007028, Dec 13, 2007
Filed:
May 23, 2007
Appl. No.:
11/752742
Inventors:
John Williams - Nashville TN, US
James Crowe - Nashville TN, US
International Classification:
A61K 39/00, A61P 43/00, C07K 14/00, C12N 15/00, C12N 15/11, C12P 21/04, G01N 33/53
US Classification:
424210100, 435320100, 435069100, 435007100, 536023100
Abstract:
The present invention provides an improved form of a nucleic acid encoding for the influenza hemagluttinin H5N1. The optimized gene sequence permits production via recombinant means, of the H5N1 HA protein for use in diagnostic assays and vaccines.